AU6346296A - Assays to evaluate chemotherapeutic effectiveness of drugs - Google Patents

Assays to evaluate chemotherapeutic effectiveness of drugs

Info

Publication number
AU6346296A
AU6346296A AU63462/96A AU6346296A AU6346296A AU 6346296 A AU6346296 A AU 6346296A AU 63462/96 A AU63462/96 A AU 63462/96A AU 6346296 A AU6346296 A AU 6346296A AU 6346296 A AU6346296 A AU 6346296A
Authority
AU
Australia
Prior art keywords
assays
drugs
evaluate
chemotherapeutic effectiveness
effectiveness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63462/96A
Inventor
Bruce Magun
Scott Mcneil
Karin D. Rodland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health Science University
Original Assignee
Oregon Health Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Health Science University filed Critical Oregon Health Science University
Publication of AU6346296A publication Critical patent/AU6346296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU63462/96A 1995-07-05 1996-07-03 Assays to evaluate chemotherapeutic effectiveness of drugs Abandoned AU6346296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80695P 1995-07-05 1995-07-05
US000806 1995-07-05
PCT/US1996/011330 WO1997002360A1 (en) 1995-07-05 1996-07-03 Assays to evaluate chemotherapeutic effectiveness of drugs

Publications (1)

Publication Number Publication Date
AU6346296A true AU6346296A (en) 1997-02-05

Family

ID=21693099

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63462/96A Abandoned AU6346296A (en) 1995-07-05 1996-07-03 Assays to evaluate chemotherapeutic effectiveness of drugs

Country Status (5)

Country Link
EP (1) EP0836650A1 (en)
JP (1) JPH11509095A (en)
AU (1) AU6346296A (en)
CA (1) CA2225997A1 (en)
WO (1) WO1997002360A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884597B1 (en) 1998-01-20 2005-04-26 Medical & Biological Laboratories, Co., Ltd. Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or enhancers of these enzymes
AU2001246863A1 (en) * 2000-04-11 2001-10-23 Sayuri Yamada Curcumin compositions
US8168568B1 (en) 2003-03-10 2012-05-01 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Combinatorial therapy for protein signaling diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2154345A1 (en) * 1993-01-21 1994-08-04 John G. Babish Products for measuring cell growth propensity and methods for their use

Also Published As

Publication number Publication date
JPH11509095A (en) 1999-08-17
CA2225997A1 (en) 1997-01-23
WO1997002360A1 (en) 1997-01-23
EP0836650A1 (en) 1998-04-22

Similar Documents

Publication Publication Date Title
AU5569896A (en) Novel synthesis and use of beta-lapachone analogs
HUP9601698A3 (en) Pharmaceutical composition of adiabetical activity
AU1322195A (en) Method of assay
AU5379296A (en) Production of rhein and rhein derivatives
AU6418596A (en) Compounds and pharmaceutical compositions containing them
GB9512290D0 (en) Uses of polyhexanide
AU1716292A (en) Assay of specific antibody
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
IL116924A0 (en) Preparation of n-aryl- and n-hetarylhydroxylamines
AU5381696A (en) Synthesis of bis-indolylmaleimides
HU9502426D0 (en) Compounds of pharmaceutical activity
AU1165697A (en) Improvements relating to assay systems
AU4224096A (en) Use of phenylcyclohexylcarboxamides
PL327538A1 (en) Novel compounds of analgesic activity
AU6346296A (en) Assays to evaluate chemotherapeutic effectiveness of drugs
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU4440596A (en) Use of hcp SH2 specific compounds to enhance erythropoiesis
AU6305696A (en) Benzylhydroxylamines and intermediates used to prepare them
AU5425194A (en) Detection of anti-hpa antibodies
AU4670696A (en) Diagnosis of toxicoinfectious clostridiosis
ZA968873B (en) Isomerisation of equillin
AU7267298A (en) Synthesis of discodermolide and analogs
IL117786A (en) Preparation of alpha-bisoximes
GB2269014B (en) Assay of NADH
AU5657596A (en) Composition of matter